Unichem Labs gets USFDA nod for hypertension drug Guanfacine

Published On 2021-03-05 06:31 GMT   |   Update On 2023-10-13 10:51 GMT

Mumbai: Drugmaker, Unichem Laboratories Limited, has recently announced that the company has received abbreviated new drug application (ANDA) approval for its Guanfacine Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENEX (Guanfacine) Tablets 1 mg and 2 mg of Promius Pharma LLC.Guanfacine Tablets are indicated in...

Login or Register to read the full article

Mumbai: Drugmaker, Unichem Laboratories Limited, has recently announced that the company has received abbreviated new drug application (ANDA) approval for its Guanfacine Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENEX (Guanfacine) Tablets 1 mg and 2 mg of Promius Pharma LLC.

Guanfacine Tablets are indicated in the management of hypertension.
The product will be commercialized from Unichem's Ghaziabad Plant.

Read also: Unichem Labs plaque psoriasis drug Apremilast gets USFDA nod

Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company.

It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News